Shed vs Regenics: Coaching and Name-Brand vs Compounded

Quick verdict: Shed vs Regenics focuses on whether you value integrated coaching and access to name-brand GLP-1 (Shed) versus lower promotional entry pricing, free shipping, and nurse-practitioner–led compounded care (Regenics). Shed pairs medications with continuous coaching and a 2-minute approval assessment; Regenics positions itself as a straightforward, nurse-practitioner–led telehealth option with compounded semaglutide starting at $139 first month.

Explore Shed’s name-brand and compounded GLP-1 options

How the two providers differ at a glance

This comparison highlights five supported differences: medication types offered, coaching and clinical model, pricing and promotional structure, shipping and pharmacy notes, and assessment or approval process. All statements preserve source qualifiers about compounded medications and clinician review.

1. Medication options: name-brand plus compounded vs compounded only

Shed offers both FDA-approved name-brand GLP-1 medications and compounded alternatives on one platform, letting patients choose based on budget and preference. The source emphasizes that name-brand options carry higher costs but provide regulatory assurance, while compounded options are more affordable. Regenics offers compounded semaglutide and tirzepatide prepared by U.S. licensed compounding pharmacies and also markets an injectable peptide, Sermorelin. Both providers note that compounded medications are not FDA-approved as finished products and are prepared by licensed pharmacies based on a provider’s prescription.

2. Care model and coaching vs nurse-practitioner oversight

Shed integrates continuous coaching into treatment rather than simply issuing a prescription, positioning coaching as part of the bundled monthly cost and supporting titration and lifestyle changes. Regenics delivers care under licensed nurse practitioners who review intake and oversee prescriptions; the platform is described as nurse-practitioner-led and straightforward for cash-pay entry. These are distinct approaches: Shed emphasizes behavioral support alongside medication, while Regenics emphasizes clinician oversight by NPs and a simpler telehealth workflow.

See Regenics’ compounded GLP-1 pricing and NP oversight

3. Pricing and promotions: starting prices and first-month deals

Shed lists compounded semaglutide starting at $199/month and compounded tirzepatide starting at $299/month, and it advertises a limited-time 10% off your first month. Shed does not publish a single standard price and provides personalized quotes after intake; coaching is bundled into the monthly cost. Regenics promotes promotional first-month pricing: semaglutide $139 first month (renewing $199/mo) and tirzepatide $189 first month (renewing $279/mo). Regenics’ promotional pricing applies to the first month only, with renewals at higher rates according to the source.

4. Shipping, pharmacy network, and extras

Regenics states medications are compounded in the USA, shipped free, and its pharmacy network is LegitScript certified. Shed’s captured landing-page details list starting prices and the 10% first-month offer but do not duplicate Regenics’ free-shipping claim; both stress that compounded medications are not FDA-approved and require a licensed provider’s prescription. Regenics also offers Sermorelin peptide therapy as an additional product line; Shed highlights the option to explore a Shed Membership.

5. Assessment and approval timing

Shed promotes a 2-minute approval assessment to check eligibility quickly, followed by clinician review and a prescription only when a licensed provider determines treatment is appropriate. Regenics requires intake review by a licensed nurse practitioner before prescribing. Both platforms make clear treatment is available only when a licensed clinician determines it is medically appropriate.

Comparison table: Shed vs Regenics

Start Shed’s 2-minute assessment and view options

Synthesis: who benefits from each approach?

If you want the option of FDA-approved name-brand GLP-1 alongside compounded alternatives and integrated behavioral support, Shed emphasizes coaching integrated into treatment and a fast eligibility check, plus a 10% first-month offer. If your priority is the lowest promotional entry price for compounded semaglutide or tirzepatide, free shipping from U.S. compounding pharmacies, and NP oversight in a telehealth model, Regenics positions itself around those points with first-month pricing as low as $139.

Compare Regenics’ first-month pricing and shipping

Conclusion: Shed vs Regenics

In the Shed vs Regenics comparison, choose based on care priorities: Shed emphasizes integrated coaching plus access to name-brand and compounded GLP-1 with a 2-minute assessment and a 10% first-month offer. Regenics emphasizes lower promotional first-month pricing for compounded GLP-1, free U.S. shipping, and nurse-practitioner–led telehealth oversight. Both require licensed clinician review and note that compounded medications are not FDA-approved as finished products.

Choose Shed if you want integrated continuous coaching and the option to access FDA-approved name-brand GLP-1 as well as compounded choices, with a 2-minute assessment and a first-month promotion.

Choose Regenics if you prioritize lower first-month compounded pricing, free shipping from U.S. compounding pharmacies, and nurse-practitioner–led telehealth care.